CALCIUM ANTAGONISTS
Dihydropyridine calcium channel blockers
(nicardipine, clevidipine) are arterial selective vasodilators routinely used
for perioperative blood pressure control in patients undergoing cardiothoracic
surgery. Clevidipine is a relatively new drug with a short half- life, which
facilitates its rapid titration. Unlike verapamil and diltiazem, the dihydropyridine
calcium channel blockers have minimal effects on cardiac conduction and
ventricular contractility. Calcium channel block-ers bind to L-type calcium
channel and impair cal-cium entry into the vascular smooth muscle. These L-type
receptors are more prevalent on arterial ves-sels than venous capacitance
vessels. Consequently, cardiac filling and preload is less affected by these
agents than nitrates, which might dilate both arte-rial and venous systems.
With preload maintained, cardiac output often increases when vascular tone is
reduced by use of dihydropyridine calcium blockers. Nicardipine infusion is
titrated to effect (5–15 mg/h).
Other intravenous agents that can
produce hypotension perioperatively include the intravenous
angiotensin-converting enzyme inhibitor enala-prilat (0.625–1.25 mg). The role
of enalaprilat as a nondirect-acting agent in the acute treatment of a
hypertensive crisis is limited.
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.